1. Home
  2. CPAC vs JANX Comparison

CPAC vs JANX Comparison

Compare CPAC & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cementos Pacasmayo S.A.A. (Each representing five)

CPAC

Cementos Pacasmayo S.A.A. (Each representing five)

HOLD

Current Price

$10.33

Market Cap

848.5M

Sector

Industrials

ML Signal

HOLD

Logo Janux Therapeutics Inc.

JANX

Janux Therapeutics Inc.

HOLD

Current Price

$13.55

Market Cap

790.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPAC
JANX
Founded
1949
2017
Country
Peru
United States
Employees
N/A
N/A
Industry
Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
848.5M
790.3M
IPO Year
2003
2021

Fundamental Metrics

Financial Performance
Metric
CPAC
JANX
Price
$10.33
$13.55
Analyst Decision
Hold
Strong Buy
Analyst Count
2
11
Target Price
$12.90
$53.60
AVG Volume (30 Days)
15.0K
834.3K
Earning Date
04-27-2026
05-07-2026
Dividend Yield
5.47%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$10,000,000.00
Revenue This Year
$4.49
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$19.78
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.10
$12.12
52 Week High
$11.50
$35.34

Technical Indicators

Market Signals
Indicator
CPAC
JANX
Relative Strength Index (RSI) 49.92 44.13
Support Level $10.25 $13.12
Resistance Level $11.37 $13.79
Average True Range (ATR) 0.32 0.50
MACD 0.02 -0.04
Stochastic Oscillator 75.63 7.04

Price Performance

Historical Comparison
CPAC
JANX

About CPAC Cementos Pacasmayo S.A.A. (Each representing five)

Cementos Pacasmayo SAA is a Peruvian cement company that produces, distributes, and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. The company's products are used in construction. It also produces and sells quicklime for use in mining operations. The company sells its products mainly in the northern part of Peru. It owns three cement production and transportation facilities. Its flagship Pacasmayo facility is located in the northwest region of Peru, while its new cement plant in Piura and smaller Rioja facility are located in the northeast region of Peru.

About JANX Janux Therapeutics Inc.

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

Share on Social Networks: